Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Stud... by Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi

Get full text

Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases by Sadegh Mousavi, Katja Bieber, Henner Zirpel, Artem Vorobyev, Henning Olbrich, Cristian Papara, Cristian Papara, David A. De Luca, David A. De Luca, Diamant Thaci, Enno Schmidt, Gabriele Riemekasten, Peter Lamprecht, Matthias Laudes, Khalaf Kridin, Khalaf Kridin, Khalaf Kridin, Ralf J. Ludwig, Ralf J. Ludwig

Get full text

Meeting Report on “10th Anniversary Symposium on Inflammatory Skin Disease” by Shirin Emtenani, John F. Baines, Katja Bieber, Evelyn Gaffal, Stephanie Goletz, Gema Hernández, Misa Hirose, Markus Hoffmann, Pascal Joly, Henriette Kirchner, Jörg Köhl, Sripriya Murthy, Sabrina Patzelt, Frank Petersen, Manuela Pigors, Gabriela Riemekasten, Leon F. Schmidt-Jiménez, Tanya Sezin, Malte Spielmann, Diamant Thaçi, Nina van Beek, Jens Waschke, Ralf J. Ludwig, Enno Schmidt

Get full text